IL68456A - Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles - Google Patents

Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles

Info

Publication number
IL68456A
IL68456A IL68456A IL6845683A IL68456A IL 68456 A IL68456 A IL 68456A IL 68456 A IL68456 A IL 68456A IL 6845683 A IL6845683 A IL 6845683A IL 68456 A IL68456 A IL 68456A
Authority
IL
Israel
Prior art keywords
vehicles
perfluoro
pharmaceutical compositions
substituted compounds
substituted
Prior art date
Application number
IL68456A
Other languages
English (en)
Other versions
IL68456A0 (en
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of IL68456A0 publication Critical patent/IL68456A0/xx
Publication of IL68456A publication Critical patent/IL68456A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL68456A 1982-04-05 1983-04-21 Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles IL68456A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36553982A 1982-04-05 1982-04-05

Publications (2)

Publication Number Publication Date
IL68456A0 IL68456A0 (en) 1983-07-31
IL68456A true IL68456A (en) 1989-09-28

Family

ID=23439275

Family Applications (1)

Application Number Title Priority Date Filing Date
IL68456A IL68456A (en) 1982-04-05 1983-04-21 Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles

Country Status (12)

Country Link
EP (1) EP0091313B1 (xx)
KR (1) KR880002038B1 (xx)
AT (1) ATE56138T1 (xx)
AU (1) AU557980B2 (xx)
CA (1) CA1295948C (xx)
DE (1) DE3381854D1 (xx)
GR (1) GR78151B (xx)
IE (1) IE56412B1 (xx)
IL (1) IL68456A (xx)
NZ (1) NZ203802A (xx)
PT (1) PT76504B (xx)
WO (1) WO1983003544A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU559559B2 (en) * 1982-08-17 1987-03-12 Suntech, Inc. Perfluorocarbon emulsions and their preparation and use in therapy
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
DE69226372T2 (de) * 1991-11-14 1999-04-01 Alliance Pharma Vorrichtung zur teilweisen flüssigen beatmung mit fluorkohlenwasserstoffen
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
ATE196734T1 (de) * 1993-08-18 2000-10-15 Alcon Lab Inc Zusammensetzungen von ergolinderivaten zur behandlung des glaukoms
ATE206441T1 (de) 1994-03-04 2001-10-15 Univ Washington Block- und pfropfcopolymere und dazu gehöriges verfahren
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
AU2001211986B2 (en) * 2000-10-13 2007-04-26 Cambridge Biostability Ltd. Composition and method for stable injectable liquids
DE60043459D1 (de) * 2000-10-13 2010-01-14 Cambridge Biostability Ltd Pharmazeutische flüssige Suspensionen
DE102006040450B3 (de) * 2006-08-24 2008-04-24 Coty Prestige Lancaster Group Gmbh Verwendung einer Zusammensetzung für die Hautbehandlung nach Röntgenbestrahlung
CN104755073B (zh) * 2012-09-12 2017-12-26 诺瓦利克有限责任公司 半氟化烷烃组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2968628A (en) * 1958-10-17 1961-01-17 Shulton Inc Propellant composition
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
BE629985A (xx) * 1962-11-29
US3490923A (en) * 1966-07-28 1970-01-20 Du Pont Aerosol propellant composition used in dispensing foods
US3958014A (en) * 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
US3929662A (en) * 1973-12-18 1975-12-30 Wave Energy Systems Liquid or gas phase sterilizing and cleaning composition containing an aldehyde and a fluoro or perfluoro compound
US4187252A (en) * 1977-08-26 1980-02-05 Suntech, Inc. Tetramethylpentane blood substitutes
US4110474A (en) * 1977-08-26 1978-08-29 Suntech, Inc. Tetramethylpentane blood substitutes
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
JPH08221312A (ja) * 1995-02-14 1996-08-30 Hitachi Ltd メモリカード装置

Also Published As

Publication number Publication date
IL68456A0 (en) 1983-07-31
EP0091313A2 (en) 1983-10-12
EP0091313B1 (en) 1990-09-05
ATE56138T1 (de) 1990-09-15
CA1295948C (en) 1992-02-18
KR840004366A (ko) 1984-10-15
NZ203802A (en) 1985-07-31
DE3381854D1 (de) 1990-10-11
AU557980B2 (en) 1987-01-15
PT76504A (en) 1983-05-01
IE56412B1 (en) 1991-07-31
EP0091313A3 (en) 1985-05-22
GR78151B (xx) 1984-09-26
WO1983003544A1 (en) 1983-10-27
PT76504B (en) 1986-02-27
KR880002038B1 (ko) 1988-10-13
AU1313883A (en) 1983-10-13
IE830776L (en) 1983-10-05

Similar Documents

Publication Publication Date Title
IL68456A (en) Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles
GB2129691B (en) Devices for administering medicaments to patients
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
EP0202051A3 (en) Therapeutic compositions for oral administration
GB2142237B (en) Pharmaceutical compositions for percutaneous administration
CY1401A (en) Bandage for administering drugs.
NL930112I1 (nl) Benzazepine-2-onen werkwijzen ter bereiding daarvan farmaceutische preparaten die deze verbindingen bevatten alsmede verbindingen voor de therapeutische toepassing
GB8602264D0 (en) Administering medicaments to patients
ES8304147A1 (es) Procedimiento para la preparacion de mono-esteres amonio-al-cohilicos de acidos alcanol-fosforicos
DE3779053D1 (xx)
GB2085729B (en) Pharmaceutical composition for oral administration containing coagulation factor viii
AU7080587A (en) Therapeutic compositions for veterinary use
HUT62471A (en) Process for producing pharmaceutical compositions comprising ipriflavone
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
ZA81927B (en) Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds
GB2052980B (en) Pharmaceutical composition for oral administration comprising methoxsalen
ZA814430B (en) Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator
PT76999B (en) Process for preparing pharmaceutical compositions having analgesic activity
ZA837318B (en) Device for administering medicaments to patients
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
IT8349055A0 (it) B-osso-l-carbammoil-pirrolpropionitrile, procedimento per la loro produzione, preparati farmaceutici con tenenti questi composti, nonche' il loro impiego terapeutico
GB2142238B (en) Pharmaceutical compositions for percutaneous administration
ZA832489B (en) Perfluorohydrocarbons as vehicles for administering drugs
ATA407483A (de) Verfahren und vorrichtung zum entfetten eines veroelten, insbesondere von oelbehaeltern stammenden polyaethylen-werkstoffgutes

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees